Sökning: onr:"swepub:oai:prod.swepub.kib.ki.se:135929671" >
A comparative analy...
A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy
-
Noorani, A (författare)
-
Bornschein, J (författare)
-
Lynch, AG (författare)
-
visa fler...
-
Secrier, M (författare)
-
Achilleos, A (författare)
-
Eldridge, M (författare)
-
Bower, L (författare)
-
Weaver, JMJ (författare)
-
Crawte, J (författare)
-
Ong, CA (författare)
-
Shannon, N (författare)
-
MacRae, S (författare)
-
Grehan, N (författare)
-
Nutzinger, B (författare)
-
O'Donovan, M (författare)
-
Hardwick, R (författare)
-
Tavare, S (författare)
-
Fitzgerald, RC (författare)
-
visa färre...
- 2017-05-02
- 2017
- Engelska.
-
Ingår i: Genome research. - : Cold Spring Harbor Laboratory. - 1549-5469 .- 1088-9051. ; 27:6, s. 902-912
- Relaterad länk:
-
http://genome.cshlp....
-
visa fler...
-
http://kipublication...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- The scientific community has avoided using tissue samples from patients that have been exposed to systemic chemotherapy to infer the genomic landscape of a given cancer. Esophageal adenocarcinoma is a heterogeneous, chemoresistant tumor for which the availability and size of pretreatment endoscopic samples are limiting. This study compares whole-genome sequencing data obtained from chemo-naive and chemo-treated samples. The quality of whole-genomic sequencing data is comparable across all samples regardless of chemotherapy status. Inclusion of samples collected post-chemotherapy increased the proportion of late-stage tumors. When comparing matched pre- and post-chemotherapy samples from 10 cases, the mutational signatures, copy number, and SNV mutational profiles reflect the expected heterogeneity in this disease. Analysis of SNVs in relation to allele-specific copy-number changes pinpoints the common ancestor to a point prior to chemotherapy. For cases in which pre- and post-chemotherapy samples do show substantial differences, the timing of the divergence is near-synchronous with endoreduplication. Comparison across a large prospective cohort (62 treatment-naive, 58 chemotherapy-treated samples) reveals no significant differences in the overall mutation rate, mutation signatures, specific recurrent point mutations, or copy-number events in respect to chemotherapy status. In conclusion, whole-genome sequencing of samples obtained following neoadjuvant chemotherapy is representative of the genomic landscape of esophageal adenocarcinoma. Excluding these samples reduces the material available for cataloging and introduces a bias toward the earlier stages of cancer.
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Noorani, A
-
Bornschein, J
-
Lynch, AG
-
Secrier, M
-
Achilleos, A
-
Eldridge, M
-
visa fler...
-
Bower, L
-
Weaver, JMJ
-
Crawte, J
-
Ong, CA
-
Shannon, N
-
MacRae, S
-
Grehan, N
-
Nutzinger, B
-
O'Donovan, M
-
Hardwick, R
-
Tavare, S
-
Fitzgerald, RC
-
visa färre...
- Artiklar i publikationen
-
Genome research
- Av lärosätet
-
Karolinska Institutet